![EMJ Neurology 8 [Supplement 1] 2020 Front Cover](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/10/EMJ-Neurology-8-Supplement-1-2020-Front-Cover.jpg)
Currently, 50 million people are living with Alzheimer’s disease (AD), with estimates suggesting an increase to >150 million by 2050. This summary of a satellite symposium of four expert talks on 28th July 2020 at the online 2020 Alzheimer’s Association International Conference (AAIC) aims to empower healthcare professionals (HCP) to support early diagnosis, prevention, and management of AD.
Latest articles
All articles
18 Mins
27
Jan
New Advances in the Treatment of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy
Both spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are monogenic neuromuscular diseases, which cause progressive proximal-to-distal muscular weakness, leading to loss of motor function and related pulmonary and musculoskeletal co-morbidities and reduced survival.